Cerebral aspergillosis: long term efficacy and safety of liposomal amphotericin B in kidney transplant

被引：10
|
作者：
Carlini, A [1 ]
Angelini, D
Burrows, L
De Quirico, G
Antonelli, A
机构：
[1] Campo Marte Hosp, Dept Nephrol, I-55100 Lucca, Italy
[2] Campo Marte Hosp, Dept Radiol, I-55100 Lucca, Italy
[3] Mt Sinai Hosp, Dept Renal Transplantat, New York, NY 10029 USA
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 1998年 / 13卷 / 10期
关键词：
cerebral aspergillosis; liposomal amphotericin B; nefrotoxicity; renal transplant;
D O I：
10.1093/ndt/13.10.2659
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：2659 / 2661
页数：3
相关论文
共 50 条
  • [41] The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis
    Ibrahim, Ashraf S.
    Gebremariam, Teclegiorgis
    French, Samuel W.
    Edwards, John E., Jr.
    Spellberg, Brad
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (02) : 289 - 292
  • [42] A Case of Refractory Pulmonary Aspergillosis Treated with Micafungin and Liposomal Amphotericin B
    Lodhi, W.
    Ghimirey, N.
    Wajahat, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [43] Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin
    Graybill, JR
    Bocanegra, R
    Gonzalez, GM
    Najvar, LK
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (04) : 656 - 662
  • [44] Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B
    Offner, F
    Krcmery, V
    Boogaerts, M
    Doyen, C
    Engelhard, D
    Ribaud, P
    Cordonnier, C
    de Pauw, B
    Durrant, S
    Marie, JP
    Moreau, P
    Guiot, H
    Samonis, G
    Sylvester, R
    Herbrecht, R
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) : 4808 - 4812
  • [45] Treatment of disseminated aspergillosis with voriconazole/liposomal amphotericin B in a child with leukemia
    Athanassiadou, F
    Tragiannidis, A
    Kourti, M
    Papageorgiou, T
    Velegraki, A
    Kalogera, A
    PEDIATRIC BLOOD & CANCER, 2005, 45 (07) : 1003 - 1004
  • [46] Combined High-Dose Caspofungin and Liposomal Amphotericin B for Treatment of Azole-Resistant Cerebral Aspergillosis
    Pouvaret, A.
    Dureault, A.
    Garcia-Hermoso, D.
    Serris, A.
    Cohen, J. F.
    Guery, R.
    Lanternier, F.
    Lortholary, O.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (10)
  • [47] LIPOSOMAL AMPHOTERICIN-B (AMBISOME) TREATMENT IN SOLID ORGAN AND BONE-MARROW TRANSPLANT RECIPIENTS - EFFICACY AND SAFETY EVALUATION
    TOLLEMAR, J
    RINGDEN, O
    TYDEN, G
    CLINICAL TRANSPLANTATION, 1990, 4 (03) : 167 - 175
  • [48] Isolated cerebral aspergillosis without a portal of entry - complete recovery after liposomal amphotericin B and surgical treatment
    Garcia, A
    Mazuecos, A
    Clavo, A
    Perez-Requena, J
    Mangas, A
    Alonso, F
    Ceballos, M
    Rivero, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (09) : 2385 - 2387
  • [49] Caspofungin vs. caspofungin combined with liposomal amphotericin B for the treatment of cerebral aspergillosis in a nursing rat model
    Strahm, R.
    Leib, S. L.
    Kummer, J.
    Zimmerli, S.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2006, 10 : S56 - S56
  • [50] Pharmacokinetics and Pharmacodynamics of Amphotericin B Deoxycholate, Liposomal Amphotericin B, and Amphotericin B Lipid Complex in an In Vitro Model of Invasive Pulmonary Aspergillosis
    Lestner, Jodi M.
    Howard, Susan J.
    Goodwin, Joanne
    Gregson, Lea
    Majithiya, Jayesh
    Walsh, Thomas J.
    Jensen, Gerard M.
    Hope, William W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (08) : 3432 - 3441
12345